AstraZeneca opens $1bn R&D centre in US

AstraZeneca has now opened its new research and development centre in Cambridge, Massachusetts – an investment of nearly 1 billion dollars.

Orexo seeks SEK 250 million to fund pipeline and DOJ settlement

Orexo had SEK 118.7 million in available cash at the end of August. The Uppsala-based company now wants to raise a further SEK 250 million to fund its developme...

Nobel discovery helps explain cause and effect in the brain

“Optogenetics is a revolutionary technique that allows us to study the brain in an entirely new way,” says Linda Engström Ruud, associate professor of physiolog...

CTIS updates strengthen compliance and transparency

The Clinical Trials Information System (CTIS) has introduced several updates aimed at improving safety reporting, communication, and regulatory compliance for sponsors.

Novo's facility remediation delays haemophilia A drug

The FDA has informed Novo that the BLA review of the antibody denecimig for the treatment of haemophilia A is still ongoing with no new timeline.

Genmab scores Phase 3 win in blood cancer trial

Genmab and AbbVie report positive results from a late-stage study evaluating the bispecific antibody epcoritamab in the most common type of non-Hodgkin lymphoma.

Omnio raises €2.9m for chronic wound therapy

Swedish biotech company Omnio has secured €2.9 million from existing investors and shareholders. The funding will be used to advance its plasminogen-based biolo...

Russian lab worker’s death sparks suspected plague investigation

Russian authorities have placed around 200 people under medical observation amid suspicions of plague, following the death of a 28-year-old laboratory worker in...

Under-pressure CSL strikes billion-dollar deal – bets on new phase II candidate

Job cuts, a lowered earnings forecast and concerns over its vaccine business have put CSL under pressure. Now the Australian pharmaceutical giant is making a ma...

Stort intresse för IVDR- och MDR-webbinarium

Intresset är stort för vårt kommande webbinarium om IVDR- och MDR-certifieringsprocesserna. Webbinariet riktar sig särskilt till konsultföretag som stödjer till...

Discoveries in optogenetics awarded Nobel medicine prize

The 2026 Nobel Prize in Physiology or Medicine is awarded to Karl Deisseroth, Peter Hegemann and Georg Nagel “for their discoveries concerning light-gated ion c...

New AI model could reduce unnecessary surgery for women

Every misjudged ovarian abnormality costs time, money and unnecessary anxiety. A new AI model may offer a solution – once it is fully implemented into the patient pathway.

Alligator slims down as new CEO takes over

Alligator Bioscience has appointed Johan Giléus as its new CEO, succeeding Søren Bregenholt, who will leave the company at the end of the year.

Pharma Outsourcing – Find the Right Partner

Novartis strikes $7.8bn deal with Chinese biotech

Novartis has signed a multibillion-dollar licensing deal with Chinese biotech company Abogen in the field of autoimmune diseases.

Nordland Automatic A/S

Maskinsikkerhed ApS

Anocca doses first Swedish patient with its TCR-T therapy

Five patients have so far been treated with Anocca’s in-house developed TCR-T cell therapy candidate for pancreatic cancer, with the latest becoming the first p...

Busch Vakuumteknik A/S

New heart valve can expand as children grow

The US Food and Drug Administration (FDA) has approved a surgically implanted heart valve for children with a special feature: it can be expanded as the child grows.

KS Gruppen A/S

ELINDCO A/S

Danish diabetes firm secures MDR approval: “It's not something that you just do”

After formerly obtaining a regulatory for patients over 18 years old, Hedia can now expand its support to pediatric care.

Phase III goals met – yet Zealand shares fall

Despite meeting both primary endpoints in a Phase 3 trial of the obesity drug survodutide, Zealand Pharma’s shares fell sharply on Thursday.